Paul Strumph, MD


Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MD

The lead of the Myasthenia Gravis Foundation of America Global Myasthenia Gravis Patient Registry spoke on 2 additional attributes of the patient registry. [WATCH TIME: 3 minutes]

Gloria von Geldern, MD


Multiple Sclerosis Care During a Pandemic

Join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.

Calaneet Balas, MSc, MBA


Addressing the Greatest Needs in ALS: Calaneet Balas, MSc, MBA

The president and chief executive officer of The ALS Association provided insight on the most pressing needs for patients with ALS and the organization’s focus going forward. [WATCH TIME: 5 minutes]

Douglas Sproule, MD, MSc


The Use of Molecular Testing in Limb Girdle Muscular Dystrophy: Douglas Sproule, MD, MSc

The chief medical officer at ML Bio Solutions spoke about the advances in neuromuscular diseases such as limb girdle muscular dystrophy at the 2023 MDA Conference. [WATCH TIME: 3 minutes]

Christian Meisel, MD


Christian Meisel, MD, PhD: Treatment Landscape for Seizure Forecasting Devices

The neurologist from Universitätsmedizin Berlin and Berlin Institute of Health provided his insight on the reasons for the limited number of FDA-approved seizure forecasting devices.

Melanie Truong-Le, DO, OD


Addressing the Current State of Care, Pipeline in NMOSD: Melanie Truong-Le, DO, OD

The neuro-ophthalmologist at UT Southwestern further discussed the high cost of treatment for patients with neuromyelitis optica spectrum disorder and the need to improve access to care.

Wendy Troxel, PhD


The Science of Sleep Health and Romantic Relationships: Wendy Troxel, PhD

For Valentine’s Day, the senior behavioral scientist at the RAND Corporation talked about the significance of sleep health and romantic relationships [WATCH TIME: 5 minutes]

Devon Conway, MD


Choosing Therapies for Patients With MS: Devon Conway, MD

The staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic outlined the process of choosing a therapy for patients with multiple sclerosis. [WATCH TIME: 4 minutes]

Michael J. Soileau, MD


Advanced Parkinson Disease: Looking Ahead

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.

Wolfgang Muhlhofer, MD


AUPN 2022 Spring Chairs Session: Simulations for Training in Neurology

David G. Standaert, MD, PhD; Wolfgang Muhlhofer, MD; and Latisha Sharma, MD, share their experience in applying simulation-based learning in Neurology and will discuss the current state and future potential of this approach. [WATCH TIME: 1 hour, 25 minutes]

Orrin Devinsky, MD


Importance of Establishing Healthy Eating Habits in Epilepsy: Orrin Devinsky, MD

The director of the Comprehensive Epilepsy Center at NYU Langone discussed the importance of healthy eating habits and whether all individuals with epilepsy should consider dieting early in their life. [WATCH TIME: 4 minutes]

Barry Hendin, MD


Clinical Pearls for the Management of MS

Expert neurologists emphasize the importance of conversations around patient lifestyle, mental health, and comorbid conditions as keys to improve care for MS.

Sean Pittock, MD


SRNA Roundtable Discussion: Diagnosis, Presentation, and Treatment Decision Differences Among Rare Neuroimmune Disorders

Experts such as Brenda Banwell, MD; Sean Pittock, MD; and Michael Levy, MD, PhD, cover topics related to differences in rare neuroimmune disorders, how they're approached and treated.

Alesa Monk, MBA


Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

Advocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.

Jens Kuhle, MD, PhD


Expanding the Biomarker Panel in MS: Jens Kuhle, MD, PhD

The senior physician and head of the Multiple Sclerosis Centre at University Hospital Basel spoke about his partnership with Octave and their work assessing and validating biomarkers for use in multiple sclerosis. [WATCH TIME: 4 minutes]

Jonna Lorenz


SARS-CoV-2 May Alter Blood-Brain Barrier Function

There is no evidence yet that SARS-CoV-2 can pass the blood-brain barrier, though its effects on the barrier may be intensified in those with dementia.

Darin T. Okuda, MD, FAAN, FANA


Future Research Objectives and Questions for Radiologically Isolated Syndrome: Darin Okuda, MD, FAAN, FANA

The director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center discussed ways to build off the ARISE study and the unanswered questions regarding radiologically isolated syndrome. [WATCH TIME: 3 minutes]

Tally Largent-Milnes, PhD


The Endocannabinoid System and its Relationship to Migraine: Tally Largent-Milnes, PhD

The assistant professor of pharmacology at the University of Arizona College of Medicine Tucson shared her insight into the endocannabinoid system and its therapeutic potential in treating migraine. [WATCH TIME: 5 minutes]

Edritz Javelosa, PhD


Muscular Dystrophy Association: A Hybrid Conference Featuring the Latest Advances in Neuromuscular Research, Therapy, and Clinical Care

The Muscular Dystrophy Association's annual meeting will take place in-person and virtually in Nashville, Tennessee, on March 13-16, with more than 950 in-person attendees and 130 presenters.

Jacqueline Montes, PT, EdD


Prescribing Psychical Activity Regimens in Spinal Muscular Atrophy: Jacqueline Montes, PT, EdD

The associate professor of rehabilitation and regenerative medicine at Columbia University Medical Center discussed the ways clinicians go about properly prescribing exercise regimens for patients with spinal muscular atrophy. [WATCH TIME: 3 minutes]

Ralph Nixon, MD, PhD


Redefining the Understanding of Alzheimer Disease and Its Pathology: Ralph Nixon, MD, PhD

The professor of psychiatry and cell biology at NYU Langone provided commentary on new findings which challenge traditional theories on the root of Alzheimer disease and how it is targeted. [WATCH TIME: 17 minutes]

G. Abbas Kharal, MD, MPH


Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.

Stephen Rao, PhD


Monitoring Progression in Multiple Sclerosis: Stephen Rao, PhD, ABPP-Cn

The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed his investigations into improving the MSPT.

Paula K. Schweitzer, PhD


Expanding Knowledge, Treatment Options on Excessive Daytime Sleepiness: Paula K. Schweitzer, PhD

The director of research at St. Luke’s Sleep Medicine and Research Center discussed the current treatment landscape for excessive daytime sleepiness and how solriamfetol plays a role.

Stephanie J. Nahas, MD


Discussing Preventative Migraine Lifestyle Changes with Patients

Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.

Paul Lipkin, MD


Future Implications, Outlook of New CDC Developmental Milestone Guidelines: Paul Lipkin, MD

The director of medical outpatient services at the Kennedy Krieger Institute discussed the long-term effects of the updated developmental milestone guidelines and the need to judge children based on the 75th percentile. [WATCH TIME: 7 minutes]

© 2023 MJH Life Sciences

All rights reserved.